Published in AIDS Weekly, September 11th, 2000
"In simian immunodeficiency virus (SIV) models, immunization of macaques with uninfected human cells or human MHC proteins can induce xenogeneic immune responses which can protect the animals from subsequent SIV challenges," stated C.S. Delacruz and colleagues, University of Toronto, Canada. "These studies suggest that the induction of anti-MHC immune responses can be a viable vaccine strategy against HIV-1."
In previous murine studies, the researchers showed that DNA immunization...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.